"Designing Growth Strategies is in our DNA"

Pemphigus Vulgaris (PV) Treatment Market Size, Share and Global Trend By Treatment Type (Corticosteroid, Immunosuppressants, Biological Therapies, Intravenous Immunoglobulin (IVIG) Therapy , Others), By Route of Administration (Oral, Parenteral), By Distribution Channel (Hospital Pharmacy, Retail Pharmacy, Online Pharmacy) and Regional Forecast, 2024-2032

Region :Global | Report ID: FBI101032 | Status : Ongoing



Pemphigus Vulgaris (PV) is a potentially fatal autoimmune disease. It results in the development of painful blisters on the mucous membrane of the skin, mouth, throat, nose, or genitals. Pemphigus Vulgaris (PV) is rare in nature. According to the National Organisation of Rare Disorders, Pemphigus Vulgaris (PV) is estimated to affect 0.7-5 people per 1,000,000 population per year across the globe.

Pemphigus Vulgaris (PV) is caused when the immune system of the body starts attacking the proteins that are present on the skin. The rising prevalence of the disease and active government support has resulted in many clinical studies and increased research investment by pharmaceutical companies. For example, Cabaletta Bio is conducting clinical trails on DSG3-CAART, a type of cell therapy for mucosal Pemphigus Vulgaris (PV).

To gain extensive insights into the market, Request for Customization

Global Pemphigus Vulgaris (PV) treatment market growth is being driven by the rising prevalence of the Pemphigus Vulgaris (PV), increase in the research investment, and active government support. Also, increasing awareness regarding the disease, and presence of potential pipeline candidates are anticipated to further boost the global Pemphigus Vulgaris (PV) treatment market during the forecast period.

However, limited treatment options and side effects associated with the currently used non-biological drugs are the primary reasons that may hinder the growth in the global Pemphigus Vulgaris (PV) treatment market.

Key Players Covered

Some of the major companies that are present in the global Pemphigus Vulgaris (PV) Treatment market report are F. Hoffmann-La Roche Ltd, Novartis AG, GlaxoSmithKline plc, Genentech, Inc., Vifor Pharma Management Ltd., Alexion, and others.




By Treatment Type

· Corticosteroid

· Immunosuppressants

· Biological Therapies

· Intravenous Immunoglobulin (IVIG) Therapy

· Others

By Route of Administration

· Oral

· Parenteral

By Distribution Channel

· Hospital Pharmacy

· Retail Pharmacy

· Online Pharmacy

By Geography

· North America (USA and Canada)

· Europe (UK, Germany, France, Italy, Spain, Scandinavia and Rest of Europe)

· Asia Pacific (Japan, China, India, Australia, Southeast Asia and Rest of Asia Pacific)

· Latin America (Brazil, Mexico and Rest of Latin America)

· Middle East & Africa (South Africa, GCC and Rest of Middle East & Africa)


As per the current Pemphigus Vulgaris (PV) treatment market trends biological therapy segment, among the treatment type is anticipated to have a considerable growth owing to increasing demand for biological therapy for the treatment of diseases and reduced side effects. 

Key Insights

  • Prevalence of Pemphigus Vulgaris (PV) for key countries

  • Regulatory scenario for key countries

  • Pipeline Analysis

  • Patent Analysis

  • Recent industry developments such as partnerships, mergers, and acquisitions

Regional Analysis

The global Pemphigus Vulgaris (PV) treatment market has been segmented into North America, Europe, Asia Pacific, Latin America, and Middle East & Africa. North America is projected to dominate the global Pemphigus Vulgaris (PV) treatment market over the forecast period owing to the rising prevalence of the Pemphigus Vulgaris (PV), increased R&D spending, and presence of potential pipeline candidates. The Pemphigus Vulgaris (PV) treatment market in Europe is estimated to expand due to the active government support. In March 2019, Roche, one of the prominent players in the pharmaceutical industry received European Commission approval for MabThera for treating adults with Pemphigus Vulgaris (PV), which is expected to increase the market size of Europe. Improving health reforms, increasing awareness and demand for biological products is anticipated to favor the market expansion in Aisa Pacific, Latin America, and the Middle East and Africa.

Pemphigus Vulgaris (PV) Treatment Industry Developments

  • In March 2019, Roche, one of the prominent players in pharmaceutical industry received European Commission approval for MabThera for treating adults with Pemphigus Vulgaris (PV).
  • In June 2018, Argenx released the interim data form the Phase 2 proof-of- concept clinical study of efgartigimod for treating Pemphigus Vulgaris (PV).
  • Cabaletta Bio is conducting clinical trials on DSG3-CAART, a type of cell therapy for mucosal pemphigus vulgaris.

  • Ongoing
  • 2023
  • 2019-2022

Personalize this Research

  • Granular Research on Specified Regions or Segments
  • Companies Profiled based on User Requirement
  • Broader Insights Pertaining to a Specific Segment or Region
  • Breaking Down Competitive Landscape as per Your Requirement
  • Other Specific Requirement on Customization
Request Customization Banner

Healthcare Clients

Siemens Healthineers

Client Testimonials

“We are quite happy with the methodology you outlined. We really appreciate the time your team has spent on this project, and the efforts of your team to answer our questions.”

- One of the largest & renowned medical research centers based in the U.S. on a report on the U.S. NIPT Market.

“Thanks a million. The report looks great!”

- Feedback from a consultant on a report on the U.S. Beef Market.

“Thanks for the excellent report and the insights regarding the lactose market.”

- Brazil based company specializing in production of protein ingredients.

“I liked the report; would it be possible to send me the PPT version as I want to use a few slides in an internal presentation that I am preparing.”

- Global Digital Services Agency on a report on the Global Luxury Goods Market.

“This report is really well done and we really appreciate it! Again, I may have questions as we dig in deeper. Thanks again for some really good work.”

- U.S.-based biotechnology company focussing on treatment of chronic pain.

“Kudos to your team. Thank you very much for your support and agility to answer our questions.”

- Europe-based provider of solutions to automate data centre operations.

“We appreciate you and your team taking out time to share the report and data file with us, and we are grateful for the flexibility provided to modify the document as per request. This does help us in our business decision making. We would be pleased to work with you again, and hope to continue our business relationship long into the future.”

- India-based manufacturer of industrial and specialty intermediates with a strong global presence.

“I want to first congratulate you on the great work done on the Medical Platforms project. Thank you so much for all your efforts.”

- One of the largest cosmetics company in the world.

“Thank you very much. I really appreciate the work your team has done. I feel very comfortable recommending your services to some of the other startups that I’m working with, and will likely establish a good long partnership with you.”

- U.S. based startup operating in the cultivated meat market.

“We received the below report on the U.S. market from you. We were very satisfied with the report.”

- Global hearing aids manufacturer.

“I just finished my first pass-through of the report. Great work! Thank you!”

- U.S. based solar racking solutions provider.

“Thanks again for the great work on our last partnership. We are ramping up a new project to understand the imaging and imaging service and distribution market in the U.S.”

- World’s leading advisory firm.

“We feel positive about the results. Based on the presented results, we will do strategic review of this new information and might commission a detailed study on some of the modules included in the report after end of the year. Overall we are very satisfied and please pass on the praise to the team. Thank you for the co-operation!”

- Germany based machine construction company.

“Thank you very much for the very good report. I have another requirement on cutting tools, paper crafts and decorative items.”

- Japanese manufacturing company of stationery products.

“We are happy with the professionalism of your in-house research team as well as the quality of your research reports. Looking forward to work together on similar projects”

- One of the Leading Food Companies in Germany

“We appreciate the teamwork and efficiency for such an exhaustive and comprehensive report. The data offered to us was exactly what we were looking for. Thank you!”

- Intuitive Surgical

“I recommend Fortune Business Insights for their honesty and flexibility. Not only that they were very responsive and dealt with all my questions very quickly but they also responded honestly and flexibly to the detailed requests from us in preparing the research report. We value them as a research company worthy of building long-term relationships.”

- Major Food Company in Japan

“Well done Fortune Business Insights! The report covered all the points and was very detailed. Looking forward to work together in the future”

- Ziering Medical

“It has been a delightful experience working with you guys. Thank you Fortune Business Insights for your efforts and prompt response”

- Major Manufacturer of Precision Machine Parts in India

“I had a great experience working with Fortune Business Insights. The report was very accurate and as per my requirements. Very satisfied with the overall report as it has helped me to build strategies for my business”

- Hewlett-Packard

“This is regarding the recent report I bought from Fortune Business insights. Remarkable job and great efforts by your research team. I would also like to thank the back end team for offering a continuous support and stitching together a report that is so comprehensive and exhaustive”

- Global Management Consulting Firm

“Please pass on our sincere thanks to the whole team at Fortune Business Insights. This is a very good piece of work and will be very helpful to us going forward. We know where we will be getting business intelligence from in the future.”

- UK-based Start-up in the Medical Devices Sector

“Thank you for sending the market report and data. It looks quite comprehensive and the data is exactly what I was looking for. I appreciate the timeliness and responsiveness of you and your team.”

- One of the Largest Companies in the Defence Industry
We use cookies to enhance your experience. By continuing to visit this site you agree to our use of cookies . Privacy.